(Q51339510)

English

The effects of 13 wk of liraglutide treatment on endocrine and exocrine pancreas in male and female ZDF rats: a quantitative and qualitative analysis revealing no evidence of drug-induced pancreatitis.

scientific article published on 15 May 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/22589391

The effects of 13 wk of liraglutide treatment on endocrine and exocrine pancreas in male and female ZDF rats: a quantitative and qualitative analysis revealing no evidence of drug-induced pancreatitis. (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/22589391

0 references

1 reference

based on heuristic

inferred from title

Lotte Bjerre Knudsen

7

object named as

Lotte Bjerre Knudsen

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/22589391

author name string

Niels Vrang

1

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/22589391

Jacob Jelsing

2

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/22589391

Lotte Simonsen

3

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/22589391

Andres Eskjær Jensen

4

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/22589391

Inger Thorup

5

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/22589391

Henrik Søeborg

6

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/22589391

publication date

15 May 2012

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/22589391

American Journal of Physiology - Endocrinology and Metabolism

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/22589391

303

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/22589391

2

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/22589391

E253-64

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/22589391

Exenatide-induced acute pancreatitis

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00182.2012

21 January 2018

Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6).

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00182.2012

21 January 2018

Pancreatic duct replication is increased with obesity and type 2 diabetes in humans

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00182.2012

21 January 2018

Glucagon-like peptide-1 therapy and the exocrine pancreas: innocent bystander or friendly fire?

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00182.2012

21 January 2018

Exenatide (exendin-4)-induced pancreatitis: a case report.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00182.2012

21 January 2018

A cohort study of acute pancreatitis in relation to exenatide use.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00182.2012

21 January 2018

The biology of incretin hormones

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00182.2012

21 January 2018

The safety of incretin-based therapies--review of the scientific evidence

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00182.2012

21 January 2018

Pancreatitis, pancreatic, and thyroid cancer with glucagon-like peptide-1-based therapies

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00182.2012

21 January 2018

Acute pancreatitis

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00182.2012

21 January 2018

Acute pancreatitis in type 2 diabetes treated with exenatide or sitagliptin: a retrospective observational pharmacy claims analysis

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00182.2012

21 January 2018

Exenatide (exendin-4) improves insulin sensitivity and {beta}-cell mass in insulin-resistant obese fa/fa Zucker rats independent of glycemia and body weight

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00182.2012

21 January 2018

Chronic GLP-1 receptor activation by exendin-4 induces expansion of pancreatic duct glands in rats and accelerates formation of dysplastic lesions and chronic pancreatitis in the Kras(G12D) mouse model

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00182.2012

21 January 2018

Glucagon-like peptide-1 receptor activation modulates pancreatitis-associated gene expression but does not modify the susceptibility to experimental pancreatitis in mice

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00182.2012

21 January 2018

Beneficial endocrine but adverse exocrine effects of sitagliptin in the human islet amyloid polypeptide transgenic rat model of type 2 diabetes: interactions with metformin

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00182.2012

21 January 2018

Biochemical and histological effects of exendin-4 (exenatide) on the rat pancreas

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00182.2012

21 January 2018

The human GLP-1 analog liraglutide and the pancreas: evidence for the absence of structural pancreatic changes in three species.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00182.2012

21 January 2018

Stereological assessment of pancreatic beta‐cell mass development in male Zucker Diabetic Fatty (ZDF) rats: correlation with pancreatic beta‐cell function

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00182.2012

21 January 2018

The long-acting GLP-1 derivative NN2211 ameliorates glycemia and increases beta-cell mass in diabetic mice

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00182.2012

21 January 2018

Use of 125I-[Y39]exendin-4 to characterize exendin receptors on dispersed pancreatic acini and gastric chief cells from guinea pig.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00182.2012

21 January 2018

Pancreatic duct glands are distinct ductal compartments that react to chronic injury and mediate Shh-induced metaplasia

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00182.2012

21 January 2018

GLP-1 derivative liraglutide in rats with beta-cell deficiencies: influence of metabolic state on beta-cell mass dynamics

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00182.2012

21 January 2018

Central administration of GLP-1-(7-36) amide inhibits food and water intake in rats.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00182.2012

21 January 2018

Exenatide does not evoke pancreatitis and attenuates chemically induced pancreatitis in normal and diabetic rodents

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00182.2012

21 January 2018

Reversibility of hyperglycaemia and islet abnormalities in the high fat-fed female ZDF rat model of type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00182.2012

21 January 2018

Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00182.2012

21 January 2018

Identifiers

10.1152/AJPENDO.00182.2012

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/22589391

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/22589391

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51339510&oldid=1939583107"